These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. Divangahi M; Mostowy S; Coulombe F; Kozak R; Guillot L; Veyrier F; Kobayashi KS; Flavell RA; Gros P; Behr MA J Immunol; 2008 Nov; 181(10):7157-65. PubMed ID: 18981137 [TBL] [Abstract][Full Text] [Related]
3. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice. Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503 [TBL] [Abstract][Full Text] [Related]
4. Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo. Grace PS; Ernst JD J Immunol; 2016 Jan; 196(1):357-64. PubMed ID: 26573837 [TBL] [Abstract][Full Text] [Related]
5. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894 [TBL] [Abstract][Full Text] [Related]
6. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. Wang J; Santosuosso M; Ngai P; Zganiacz A; Xing Z J Immunol; 2004 Oct; 173(7):4590-7. PubMed ID: 15383593 [TBL] [Abstract][Full Text] [Related]
7. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin. Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102 [TBL] [Abstract][Full Text] [Related]
8. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819 [TBL] [Abstract][Full Text] [Related]
9. A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination. Connor LM; Harvie MC; Rich FJ; Quinn KM; Brinkmann V; Le Gros G; Kirman JR Eur J Immunol; 2010 Sep; 40(9):2482-92. PubMed ID: 20602436 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in lung macrophage control of Mycobacterium tuberculosis is modulated by T cells. Lai R; Williams T; Rakib T; Lee J; Behar SM Nat Commun; 2024 Jul; 15(1):5710. PubMed ID: 38977711 [TBL] [Abstract][Full Text] [Related]
11. Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses. Bizzell E; Sia JK; Quezada M; Enriquez A; Georgieva M; Rengarajan J J Leukoc Biol; 2018 Apr; 103(4):739-748. PubMed ID: 29345365 [TBL] [Abstract][Full Text] [Related]
12. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection. Nambiar JK; Ryan AA; Kong CU; Britton WJ; Triccas JA Eur J Immunol; 2010 Jan; 40(1):153-61. PubMed ID: 19830735 [TBL] [Abstract][Full Text] [Related]
13. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis. Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. Horvath CN; Shaler CR; Jeyanathan M; Zganiacz A; Xing Z Mucosal Immunol; 2012 Jul; 5(4):420-31. PubMed ID: 22453678 [TBL] [Abstract][Full Text] [Related]
15. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. Cowley SC; Elkins KL J Immunol; 2003 Nov; 171(9):4689-99. PubMed ID: 14568944 [TBL] [Abstract][Full Text] [Related]
16. Heterologous Boost Following Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X Front Immunol; 2018; 9():2439. PubMed ID: 30425711 [TBL] [Abstract][Full Text] [Related]
17. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice. Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812 [TBL] [Abstract][Full Text] [Related]
18. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
19. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH mBio; 2016 May; 7(3):. PubMed ID: 27222470 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]